Cargando…

Liver test abnormalities predict complicated disease behaviour in patients with newly diagnosed Crohn’s disease

BACKGROUNDS: In coeliac disease, the prevalence of liver test abnormalities (LTAs) is higher in patients with more severe mucosal inflammation. In Crohn’s disease, prognosis is related to the severity of mucosal inflammation. AIM: The aim of this study was to investigate whether the presence of LTA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barendregt, Jessika, de Jong, Myrthe, Haans, Jeoffrey J., van Hoek, Bart, Hardwick, James, Veenendaal, Roeland, van der Meulen, Andrea, Srivastava, Nidhi, Stuyt, Rogier, Maljaars, Jeroen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355514/ https://www.ncbi.nlm.nih.gov/pubmed/27900523 http://dx.doi.org/10.1007/s00384-016-2706-3

Ejemplares similares

Comment on Szczubełek et al. Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients. Nutrients 2021, 13, 4112
por: van Lingen, Emilie, et al.
Publicado: (2022)

The natural progression of a fistulizing gallstone resulting in massive gastrointestinal hemorrhage and Bouveret syndrome, a rare case
por: Hoekstra, Elmer, et al.
Publicado: (2019)

Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment
por: Biemans, Vince B. C., et al.
Publicado: (2020)

Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry – Vedolizumab
por: Biemans, Vince B.C., et al.
Publicado: (2019)

Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
por: Biemans, Vince B C, et al.
Publicado: (2020)

Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn’s Disease
por: Straatmijer, Tessa, et al.
Publicado: (2023)

The reproducibility of skeletal muscle signal intensity on routine magnetic resonance imaging in Crohn's disease
por: Spooren, Corinne E.G.M., et al.
Publicado: (2020)

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial
por: Janssen, Laura, et al.
Publicado: (2021)

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study
por: Asscher, Vera E. R., et al.
Publicado: (2020)

Cerebral magnetic resonance imaging in quiescent Crohn’s disease patients with fatigue
por: van Erp, Sanne, et al.
Publicado: (2017)

Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn’s Disease Perianal Fistulas
por: Barnhoorn, Marieke C, et al.
Publicado: (2020)

Immunomodulatory Effects of Mesenchymal Stromal Cells in Crohn's Disease
por: Molendijk, Ilse, et al.
Publicado: (2012)

Assessment of the Microbiota in Microdissected Tissues of Crohn's Disease Patients
por: De Hertogh, Gert, et al.
Publicado: (2012)

Assessing Disease Activity in Pediatric Crohn’s Disease Using Ultrasound: The Pediatric Crohn Disease Intestinal Ultrasound Score
por: van Wassenaer, Elsa A., et al.
Publicado: (2023)

Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence
por: Fons, Anne, et al.
Publicado: (2023)

Immunotherapy of Crohn's disease.
por: van Montfrans, C, et al.
Publicado: (1998)

Gut bacterial profile in patients newly diagnosed with treatment-naïve Crohn’s disease
por: Ricanek, Petr, et al.
Publicado: (2012)

Effect of Exclusive Enteral Nutrition on the Microbiota of Children With Newly Diagnosed Crohn's Disease
por: Kaakoush, Nadeem O, et al.
Publicado: (2015)

Herpes Simplex Virus Colitis in a Patient with Newly Diagnosed Crohn's Disease
por: Jafri, H., et al.
Publicado: (2018)

Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn’s disease
por: Kowalska-Duplaga, Kinga, et al.
Publicado: (2019)

Crohn’s Disease-Associated and Cryptoglandular Fistulas: Differences and Similarities
por: Zhou, Zhou, et al.
Publicado: (2023)

Adalimumab in Crohn’s disease
por: Van Assche, Gert, et al.
Publicado: (2007)

Systematic review with meta‐analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation
por: Steenstraten, Iris C., et al.
Publicado: (2019)

Experience of Disease Acceptance in Chinese Patients with Newly Diagnosed Crohn’s Disease: A Descriptive Qualitative Study
por: Wang, Ying, et al.
Publicado: (2023)

Improvement of psychological status after infliximab treatment in patients with newly diagnosed Crohn’s disease
por: Zhang, Maochen, et al.
Publicado: (2018)

An Obscure Presence of Gastroduodenal Involvement in a Newly Diagnosed Ileocolonic Crohn's Disease Patient
por: Miranda, Clive Jude, et al.
Publicado: (2022)

High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab
por: Doornekamp, Laura, et al.
Publicado: (2020)

Off‐label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis
por: Simsek, Melek, et al.
Publicado: (2019)

Clinical usefulness of the Mucosal Inflammation Noninvasive Index in newly diagnosed paediatric Crohn’s disease patients
por: Herman, Roma B., et al.
Publicado: (2021)

Magnetic Resonance Imaging Can Be Used to Assess Sarcopenia in Children with Newly Diagnosed Crohn’s Disease
por: Blagec, Paola, et al.
Publicado: (2023)

Impact of timing of primary ileocecal resection on prognosis in patients with Crohn’s disease
por: Beelen, Evelien M J, et al.
Publicado: (2023)

Assessing the feasibility of injectable growth-promoting therapy in Crohn’s disease
por: Altowati, Mabrouka A., et al.
Publicado: (2016)

Understanding Crohn's disease through genetics
por: Murthy, Aditya, et al.
Publicado: (2014)

Streptomyces thermovulgaris Bacteremia in Crohn's Disease Patient
por: Ekkelenkamp, Miquel Bart, et al.
Publicado: (2004)

Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn’s Disease: a Prospective Study Based on Clinical Risk Stratification
por: Arkenbosch, Jeanine H C, et al.
Publicado: (2022)

Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)
por: Yamamoto, Takayuki, et al.
Publicado: (2023)

CROHN'S DISEASE
Publicado: (1972)

Crohn disease
por: Geller, Stephen A, et al.
Publicado: (2015)

Crohn's Disease
Publicado: (1973)

Is It Crohn’s Disease?
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sbvmmkb1qg3fchjl8hc22gv7fb